ATHE Latest Press Releases

-- March 9, 2026 --

Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit Globe Newswire 7:25 AM

-- March 4, 2026 --

Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor Globe Newswire 7:25 AM

-- March 2, 2026 --

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments Globe Newswire 7:25 AM

-- January 30, 2026 --

Alterity Therapeutics: Appendix 4C - Q2 FY26 Quarterly Cash Flow Report & Corporate Update Globe Newswire 7:25 AM

-- January 21, 2026 --

Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026 Globe Newswire 7:25 AM

-- November 12, 2025 --

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference Globe Newswire 7:25 AM

-- November 10, 2025 --

Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System Globe Newswire 7:25 AM

-- October 31, 2025 --

Alterity Therapeutics: Appendix 4C - Q1 FY26 Quarterly Cash Flow Report Globe Newswire 7:25 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software